The increase in mergers and acquisitions in the healthcare industry has caused fees to rise to about 59% for 2015. Goldman Sachs controls 11.8% of the healthcare fees, JP Morgan is responsible for 11.2%, and Morgan Stanley has about 6.9%. The industry has seen a record of deal making as larger companies are buying up smaller rivals, and drug makers of generic medicines are creating ties with insurers.
To read more from Caroline click here
To read more from Reuters click here
Caroline Smith is currently a senior at the University of Notre Dame and is a contributor to Medical Groups. She is majoring in Science-Business and Spanish. After graduation, Caroline plans on entering the field of healthcare consulting. She is most interested in the evolving policy changes in the healthcare industry and enjoys learning about new technologies that are being developed.